Drug Trial Radar · NCT00012558
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Last checked: Nov 19, 2026Latest source record: May 4, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,000
Actual
Start
Sep 1998
Primary completion
Not stated
Study completion Sep 2005
Sponsor
- Lead sponsor
- National Institute of Mental Health (NIMH)NIH
- Sponsor type
- NIH
- First posted
- Mar 15, 2001
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.
Conditions
- Bipolar Disorder
Interventions
lithiumDrug
valproateDrug
bupropionDrug
paroxetineDrug
lamotrigineDrug
risperidoneDrug
inositolDrug
tranylcypromineDrug
Cognitive Behavioral TherapyBehavioral
Family-focused TherapyBehavioral
Interpersonal and Social Rhythms TherapyBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Stanford University School of Medicine
Stanford, California
University of Colorado, Colorado Psychiatric Health Clinical Investigation Center
Denver, Colorado
Massachusetts General Hospital
Boston, Massachusetts
University of Massachusetts Medical Center
Worcester, Massachusetts
Case Western Reserve University
Cleveland, Ohio
University of Oklahoma Health Sciences Center
Tulsa, Oklahoma
Portland Veteran's Administration Medical Center
Portland, Oregon
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania
Baylor College of Medicine
Houston, Texas
University of Texas Health Science Center at San Antonio
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.